Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

 

APGI Researchers Win Award for Outstanding Cancer Research

APGI researchers at the Garvan Institute were awarded the Cancer Institute NSW Inaugural Wildfire Award 2012. This prestigious award recognises research which has had a lasting impact on the cancer field.

The Cancer Institute NSW Premier's Awards for outstanding cancer research are the foremost awards ceremony for the cancer research sector in NSW. These awards recognise researchers contribution in making sure people with cancer have the latest and best treatment options available to them. APGI researchers at the Garvan won the Wildfire Award for the paper Margin clearance and outcome in resected pancreatic cancer. It is great for pancreatic cancer to be given this recognition and a tribute to the hard work of all the clinicians and researchers involved in APGI research.
Award recipients left to right
Christopher Scarlett, Amber Johns and David Chang

You can read the full story here.